Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture
about
Osteonectin/SPARC/BM-40 in human decidua and carcinoma, tissues characterized by de novo formation of basement membraneSPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrixAlbumin-based drug delivery: harnessing nature to cure diseaseSPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cellsInteractions of nanomaterials and biological systems: Implications to personalized nanomedicineRemodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer.Osteonectin cDNA sequence reveals potential binding regions for calcium and hydroxyapatite and shows homologies with both a basement membrane protein (SPARC) and a serine proteinase inhibitor (ovomucoid)Isolation and characterization of a cell surface albumin-binding protein from vascular endothelial cellsThe role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine.SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice.Facilitated diffusion and membrane permeation of fatty acid in albumin solutions.Evidence from molecular cloning that SPARC, a major product of mouse embryo parietal endoderm, is related to an endothelial cell 'culture shock' glycoprotein of Mr 43,000.Developmental and transformation-sensitive expression of the Sparc gene on mouse chromosome 11Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors.Secreted protein acidic and rich in cysteine is a matrix scavenger chaperone.Presence of osteonectin/SPARC in mandibular condylar cartilage of the rat.Novel role for matricellular proteins in the regulation of islet β cell survival: the effect of SPARC on survival, proliferation, and signaling.Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo.Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence.Anti-cancer role of SPARC, an inhibitor of adipogenesisSPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function.Deletion of the SPARC acidic domain or EGF-like module reduces SPARC-induced migration and signaling through p38 MAPK/HSP27 in glioma.A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cells.In-depth proteomic analysis of a mollusc shell: acid-soluble and acid-insoluble matrix of the limpet Lottia giganteaSecreted Protein Acidic and Rich in Cysteine in Ocular TissueCharacterization of an apically derived epithelial membrane glycoprotein from bovine milk, which is expressed in capillary endothelia in diverse tissues.Specific binding sites for albumin restricted to plasmalemmal vesicles of continuous capillary endothelium: receptor-mediated transcytosisMesosecrin: a secreted glycoprotein produced in abundance by human mesothelial, endothelial, and kidney epithelial cells in culture.In vivo expression of mRNA for the Ca++-binding protein SPARC (osteonectin) revealed by in situ hybridizationDifferential effects of transforming growth factor-beta on the synthesis of extracellular matrix proteins by normal fetal rat calvarial bone cell populationsFunctional mapping of SPARC: peptides from two distinct Ca+(+)-binding sites modulate cell shapeSPARC is a source of copper-binding peptides that stimulate angiogenesis.Notch signaling regulates tumor-induced angiogenesis in SPARC-overexpressed neuroblastomaSPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients.The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endothelia.The Caenorhabditis elegans homologue of the extracellular calcium binding protein SPARC/osteonectin affects nematode body morphology and mobility.MB1, a quail leukocyte-endothelium antigen: partial characterization of the cell surface and secreted forms in cultured endothelial cells.The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells.Complete response to azacitidine priming and nab-paclitaxel in non-Hodgkin lymphoma resistant to biochemotherapy.Tumor microenvironment and nanotherapeutics.
P2860
Q24298377-ED78B1E6-05C6-41CA-94BC-4878E3E1C43BQ24679549-54A5EFF1-9FF9-4324-8292-FF95ED12EDC9Q26765789-27703C52-1C53-4E17-B973-3AC51E702D32Q28345301-4C87BD24-0674-4494-97CB-CAFAA6FB27B4Q28391849-7CF98BD1-A31C-47E7-8DD1-BAB13C98A896Q30476541-DD0F6E00-4FCA-4829-99CB-B442857023EBQ33569214-78810A81-217D-4F7A-86E0-5FFA3E107687Q33613983-2F26627F-0FF3-47A1-B8DD-FC92149AA942Q33658672-A580A400-9870-47F5-880B-6EB285D8A250Q33659934-3416DBEB-DE91-4095-8936-FE43D19A4A8EQ33858128-7028F2B4-C570-430E-AFA1-08B4419624A8Q33879967-21C4EDCE-3A22-48A0-AC54-FA1BA4F79D83Q33880181-28195E22-01E5-4922-9742-28770E83578FQ33955200-2C4D2772-CEE3-42F6-952D-D41356C75CC0Q34031240-2F5614EF-F478-439E-9FB4-C5A191E36CB9Q34082375-E4E02FF8-A111-470C-A410-308B6C664EE4Q34431043-A7C310D3-7FCF-465F-91BA-D4F18A03DB80Q34447297-181901C0-0E95-4846-846C-01E998E359DCQ34581844-90A113CA-7084-4937-AFB7-81C50F25578FQ35116107-422FE87F-6FA7-417B-9844-74034342726AQ35176640-6D4B8EAE-10C4-4150-A2EA-54359977E5C7Q35730628-5BEDD71A-8D79-42EC-9E94-64C303854FCAQ36025413-893A7E13-DED6-4474-8B70-8E10B3DE1011Q36028876-3B0B3FB2-4D46-49FF-ABA6-199DFF53DD9AQ36074007-00A81171-55B6-44B2-94ED-28F6743AA1B6Q36211545-8C9B990E-DC77-48B5-93DE-C2574400462AQ36214861-1342B55C-8F61-4D04-A8B9-6F0378989A63Q36215866-CC7C5B15-825F-4B6C-B79D-76485D1327FCQ36218019-B8E045DF-EB42-4A5B-855F-759B13B0013DQ36218832-4E197298-23BD-4363-9AE7-E543E75C7DD7Q36224099-3598B9ED-1954-4675-BA76-DE44897B212AQ36234286-2BF22258-1C24-4F2B-9034-739D07FB41DBQ36481114-C24273B6-8E83-4A5F-AAEE-37305C66A769Q37162084-45CD320C-4A31-479E-9768-A82746458ED3Q37308589-D1254DD0-71E6-4B7F-9952-F748A3594F62Q37375791-A83EDCFE-B7BC-4B28-B246-AE630DE95DACQ37409204-FCE3BCE1-9892-4E32-B43E-B6FB41EE87C2Q37456339-60799BFF-2312-4AE8-855D-13977DB29FF5Q37594238-C0958D36-4052-417A-B555-E4F0AD073090Q37632757-28D1F620-DE20-4520-9B29-7900EFA649E4
P2860
Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture
description
1984 nî lūn-bûn
@nan
1984 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի մարտին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Characterization of a novel se ...... y endothelial cells in culture
@ast
Characterization of a novel se ...... y endothelial cells in culture
@en
Characterization of a novel se ...... y endothelial cells in culture
@nl
type
label
Characterization of a novel se ...... y endothelial cells in culture
@ast
Characterization of a novel se ...... y endothelial cells in culture
@en
Characterization of a novel se ...... y endothelial cells in culture
@nl
prefLabel
Characterization of a novel se ...... y endothelial cells in culture
@ast
Characterization of a novel se ...... y endothelial cells in culture
@en
Characterization of a novel se ...... y endothelial cells in culture
@nl
P2093
P1476
Characterization of a novel se ...... y endothelial cells in culture
@en
P2093
P304
P407
P577
1984-03-25T00:00:00Z